AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Meise, U Sulzenbacher, H Hinterhuber, H
Citation: U. Meise et al., Attempts to overcome the stigma of schizophrenia, F NEUR PSYC, 69, 2001, pp. S75-S80

Authors: Hausmann, A Marksteiner, J Hinterhuber, H Humpel, C
Citation: A. Hausmann et al., Magnetic stimulation induces neuronal c-fos via tetrodotoxin-sensitive sodium channels in organotypic cortex brain slices of the rat, NEUROSCI L, 310(2-3), 2001, pp. 105-108

Authors: Hinterhuber, H Liensberger, D Tasser, A Schwitzer, J Rizzuti, E Meise, U
Citation: H. Hinterhuber et al., The present state of psychiatric care in Italy, NERVENARZT, 72(7), 2001, pp. 501

Authors: Haller, R Kemmler, G Kocsis, E Maetzler, W Prunlechner, R Hinterhuber, H
Citation: R. Haller et al., Schizophrenia and violence. Results of an enquiry in an Austrian province, NERVENARZT, 72(11), 2001, pp. 859-866

Authors: Hausmann, A Weis, C Marksteiner, J Hinterhuber, H Humpel, C
Citation: A. Hausmann et al., Chronic repetitive transcranial magnetic stimulation enhances c-fos in theparietal cortex and hippocampus, MOL BRAIN R, 76(2), 2000, pp. 355-362

Authors: Deisenhammer, EA DeCol, C Honeder, M Hinterhuber, H Fleischhacker, WW
Citation: Ea. Deisenhammer et al., In-patient suicide in psychiatric hospitals, ACT PSYC SC, 102(4), 2000, pp. 290-294

Authors: Wiesenhofer, B Stockhammer, G Kostron, H Maier, H Hinterhuber, H Humpel, C
Citation: B. Wiesenhofer et al., Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are strongly expressed in human gliomas, ACT NEUROP, 99(2), 2000, pp. 131-137

Authors: Rittmannsberger, H Meise, U Schauflinger, K Horvath, E Donat, H Hinterhuber, H
Citation: H. Rittmannsberger et al., Polypharmacy in psychiatric treatment. Patterns of psychotropic drug use in Austrian psychiatric clinics, EUR PSYCHIA, 14(1), 1999, pp. 33-40

Authors: Kemmler, G Meise, U Tasser, A Liensberger, D Schifferle, I Braitenberg, M Schwitzer, J Hinterhuber, H
Citation: G. Kemmler et al., Subjective quality of life of schizophrenic patient: Effect of treatment setting, psychopathology and extrapyramidal-motoric side-effects, PSYCHIAT PR, 26(1), 1999, pp. 9-15
Risultati: 1-9 |